Market Research Logo

Medical Imaging Markets: Molecular Imaging


Attention: There is an updated edition available for this report.

Molecular imaging involves the ability to generate images of specific molecules within the body. The versatility of medical imaging modalities is continuing to increase as care givers keep older people alive longer. Age-related diseases such as cancer, stroke and heart disease represent the highest cost burden to health care in developed countries.

Kalorama Information has been noting developments in these technologies and rendering the market for them visible to market watchers and business planners. Medical Imaging Markets: Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:

  • PET
  • SPECT-Gamma Camera Systems
  • MRI
  • CT
  • Ultrasound
  • SPECT/CT
  • PET/CT

For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues.

Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets: Molecular Imaging includes:

  • Overview and Explanation of modalities and key applications
  • Over 25 Figures and Tables to make market data accessible to users
  • Review of Imaging Agents in Clinical Trials, or that are recently introduced
  • Market Size and Forecasts are developed through 2014
  • Profiles of Top Competitors in the industry
Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:
  • Heart Failure
  • Breast Biopsies
  • Treating Thyroid Cancer
  • Molecular Events
  • Nanoparticle Platform
  • Detecting Circulating Progenitor Cells
  • Molecular Level Tumor Activity
  • Brain Cell Inflammatory Response
  • Hybrid Scanner
  • Semiconductor-Based PET Scanner
  • PET Scanning Coverage
  • Motion-Frozen Technology
  • Recurring Prostate Cancer
  • Bone Imaging Alternatives
  • New Perfusion Tracer
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.


Big Players Team Up for Share of $6.6 Billion Molecular Imaging Market, Kalorama Information

The cost-savings associated with early disease detection and clinicians’ demand for better, more accurate diagnostic tools are key drivers for a predicted 5.8% yearly increase in the market for molecular imaging devices. According to a new report by healthcare market research publisher Kalorama Information, this market is expected to reach $6.6 billion by 2014.

Differing from traditional diagnostic tools, molecular imaging devices use biomarkers, which produce finer images that display molecular changes, allowing physicians to pinpoint diseases. Devices include nuclear medicine based PET, which renders metabolic information, and SPECT, which produces anatomical images. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. In tumors, they detect chemical signatures that provide an early warning. In addition, advances in these devices have recently helped to identify vulnerable plaque in at-risk cardiac patients. Kalorama notes that combining new molecular contrast agents with traditional diagnostic tools, such us Ultrasound, MRI and CT has enabled physicians to capture specific molecular pathways to track the progress of treatment.

While rapid advances in molecular imaging devices are pushing growth, physicians are even quicker to demand better products with:

  • minimal invasiveness,
  • rapid imaging processing time,
  • low imaging cost,
  • low radiation dose, and
  • optimal resolution and contrast.

“Meeting the growing demand for a better molecular imaging device is a big driver for companies seeking to break into this market,” says Bruce Carlson, publisher of Kalorama Information. “The market could even grow further if physicians’ demands are met and we see a rise in patient confidence, as this could translate into more individuals opting in for these services.”

The adoption of molecular imaging equipment is not exclusive to physicians, according to Kalorama. Pharmaceutical and biotechnology companies are also utilizing molecular imaging equipment, as it allows them to test drug candidates in vivo for mechanisms, disposition and efficacy. The big players, such as Siemens, GE Healthcare, Phillips, and Toshiba are teaming up with contrast media companies to develop the next generation of molecular imaging equipment.

Kalorama Information’s report, Molecular Imaging Markets (Market Intelligence Analysis of Market Opportunities in Molecular Imaging), contains more information on market forecasts, company profiles, and trends in the molecular imaging market.

  • Executive Summary
    • Molecular Basis of Cell Function
    • Driving Health care
    • Two Components
    • Key Modalities
    • World Market Summary
      • Market Drivers and Challenges
      • Growth Analysis
    • Methodology
  • Introduction
    • Definition
      • For Diagnosis
      • Molecular Agents
    • New Direction for Medicine
    • Modalities and Applications
      • Nuclear Medicine
        • Table Key Liquid Radionuclides
      • PET
      • SPECT and Gamma Cameras
      • CT
      • MRI
      • Ultrasound
      • Fusion Imaging
      • PET/CT
      • SPECT/CT
      • Optical Imaging
    • Drivers
    • Issues and Challenges
    • Health Care Reform
  • Research with Potential
    • Heart Failure
    • Breast Biopsies
    • Treating Thyroid Cancer
    • Molecular Events
    • Nanoparticle Platform
    • Detecting Circulating Progenitor Cells
    • Molecular Level Tumor Activity
    • Brain Cell Inflammatory Response
    • Hybrid Scanner
    • Semiconductor-Based PET Scanner
    • PET Scanning Coverage
    • Motion-Frozen Technology
    • Recurring Prostate Cancer
    • Bone Imaging Alternatives
    • New Perfusion Tracer
  • Markets
    • Overview
    • Procedures
      • Table Worldwide Molecular CT Procedures 2009
      • Table Worldwide Molecular MRI Procedures 2009
    • Forecasts
      • PET
        • Table World Medical Market for PET Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for PET Systems 2009-2014 Revenues (in billions)
        • Table World Medical Market for PET Systems 2009-2014 (Unit Sales)
        • Table US Medical Market for PET Systems 2009-2014 (Unit Sales)
        • Table Worldwide Medical PET Installed Base Units 2009
      • SPECT-Gamma Camera Systems
        • Table World Medical Market for SPECT Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for SPECT Systems 2009-2014 Revenues (in billions)
        • Table World Medical Market for SPECT Systems 2009-2014 (Unit Sales)
        • Table US Medical Market for SPECT Systems 2009-2014 (Unit Sales)
        • Table Worldwide Medical SPECT Installed Base, Units 2009
      • MRI
        • Table World Medical Market for MRI Molecular Imaging Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for MRI Molecular Imaging Systems 2009-2014 Revenues (in billions)
      • CT
        • Table World Medical Market for CT Molecular Imaging Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for CT Molecular Imaging Systems 2009-2014 Revenues (in billions)
      • Ultrasound
        • Table World Medical Market for Ultrasound Molecular Imaging Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for Ultrasound Molecular Imaging Systems 2009-2014Revenues (in billions)
      • Fusion Imaging
        • Table World Medical Market for PET/CT Imaging Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for PET/CT Imaging Systems 2009-2014 Revenues (in billions)
        • Table World Medical Market for SPECT/CT Imaging Systems 2009-2014 Revenues (in billions)
        • Table US Medical Market for SPECT/CT Imaging Systems 2009-2014 Revenues (in billions)
      • Optical Imaging
  • Corporate Profiles
    • Advanced Biomarker Technologies
    • Agilent Technologies
    • Avid Radiopharmaceuticals Inc.
    • Bioscan
    • Capintec Inc.
    • Cardinal Health
    • Clinical Data Inc.
    • Digirad Corp.
    • Dilon Diagnostics
    • Gamma Medica-Ideas Inc.
    • GE Healthcare
    • Hitachi Medical Systems America Inc.
    • MIR Preclinical Services
    • OptoSonics Inc.
    • Philips Healthcare
    • PhotoDetection Systems Inc.
    • Positron Corp.
    • Shimadzu Corp.
    • Siemens Healthcare
    • Spectrum Dynamics Ltd.
    • Toshiba America Medical Systems
    • UltraSPECT Ltd.
    • VisEn Medical Inc.
    • Zecotek Photonics Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report